MS‐1020 is a novel small molecule that selectively inhibits JAK3 activity
Byung‐Hak Kim(New York Medical College), Gyeong‐Hun Baeg(New York Medical College)
Cited by 33
Related Papers
A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cells
|Molecular Cancer Therapeutics|2008|38